Loading quotes...
Forecast
The analysts' average price target is €102.43 (+3.06%). The median is €105.14 (+5.79%).
| Buy |
9 |
| Hold |
18 |
| Sell |
5 |
News Go to news feed
Aflac uses high‑yield environment in Japan to reposition portfolio and drive growth
At the KBW Insurance Conference 2026, Aflac presented a strategy of capital discipline, selective growth and operational improvements. The company repositioned roughly 5% of its Japan portfolio, boosting net investment income and reducing valuation risks, while savings and life products and the new reinsurance offering Aflac Re are providing growth. In the US, Aflac is selectively expanding group and direct business as well as dental and vision benefits, but expects significant scale effects only in 2–3 years. AI is expected to deliver efficiency gains, but is not seen as the primary lever to lower expense ratios; the capital position remains comfortably above target levels. » More on de.investing.com
Aflac stock under pressure after ex-dividend dip and Wolfe 'underperform'
Aflac shares fell about 0.6% in premarket trading to $121.02 after the ex-dividend date for the quarterly dividend of $0.61 per share. Additional pressure came from Wolfe Research’s downgrade to “Underperform” with a $103 price target—implying roughly 15% downside—and from a partial share sale by Japan Post Holdings. Analysts point to a slowing core business in Japan, EPS supported by buyback-driven growth, and weak Q2 results, leaving Aflac’s Japan strategy and capital allocation under continued scrutiny. » More on de.investing.com
Aflac reaches record high of $122.93
Aflac shares rose to an all-time high of $122.93 and delivered a total return of 22.59% over the past year. Valuation metrics show a P/E ratio of 13.85 and a low PEG of 0.37, while InvestingPro rates the stock slightly above its fair-value estimate. For Q1 2026, Aflac reported revenue of $4.35 billion (expectation $4.18 billion); adjusted EPS was $1.75, just below the $1.80 estimate. The company highlights its strong dividend track record (42 consecutive years of increases) and operational initiatives such as opening an office in South Portland, Maine. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 3.58bn | 0.03% |
| Gross profit | 1.95bn | 94.77% |
| Net profit | 722.87m | 42.24% |
| EBITDA | 927.91m | 33.05% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €50.27bn |
Number of shares | 508.99m |
52-week high/low | €112.22 - €90.86 |
Dividend yield | 2.08% |
Dividends TTM | €2.07 |
Beta | 0.58 |
P/E ratio | 12.30 |
PEG ratio | 0.11 |
P/B ratio | 1.91 |
P/S ratio | 3.22 |
Company profile
Aflac Incorporated bietet über ihre Tochtergesellschaften zusätzliche Kranken- und Lebensversicherungsprodukte an. Das Unternehmen ist in zwei Segmenten tätig: Aflac Japan und Aflac U.S. Das Segment Aflac Japan bietet in Japan Krebs-, Kranken-, Pflegegeld-, GIFT-, Voll- und Risikolebensversicherungen sowie WAYS- und Kinderausstattungspläne im Rahmen von Sparprodukten an. Das Segment Aflac U.S. bietet in den Vereinigten Staaten Krebs-, Unfall-, Kurzzeitinvaliditäts-, Critical-Illness-, Krankenhausentschädigungs-, Zahn-, Sehkraft-, Langzeitpflege- und Invaliditäts- sowie Risiko- und Volllebensversicherungsprodukte an. Das Unternehmen vertreibt seine Produkte über Vertriebsmitarbeiter, Makler, unabhängige Unternehmensagenturen, Einzelagenturen und angeschlossene Unternehmensagenturen. Das Unternehmen wurde 1955 gegründet und hat seinen Sitz in Columbus, Georgia.
| Name | AFLAC |
| CEO | Daniel Paul Amos |
| Headquarters | Columbus,
ga USA |
| Website | |
| Sector | Financials |
| Industry | Insurance |
| IPO | 17/03/1980 |
| Employees | 12,716 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | AFL |
London Stock Exchange | 0H68.L |
XETRA | AFL.DE |
Frankfurt | AFL.F |
Düsseldorf | AFL.DU |
Hamburg | AFL.HM |
London | 0H68.L |
SIX | AFL.SW |
München | AFL.MU |
Wien | AFL.VI |